Summit Therapeutics (SMMT) Q4 2025 Earnings

20OctConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.76
-0.53
-0.31
-0.08

Details

Expected EPS
-0.170054
Actual EPS
-0.31
Surprise EPS
-0.14
Surprise Percent
+82.3%

Description

Summit Therapeutics (SMMT) has reported earnings of -0.31 per share for Q4 2025.

0 Comments

Share your thoughts